第 1 到 28 筆結果,共 28 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2019 | Taiwan's health-care system and administration are independent of China | Tsai D.-H.; Lee M.-H.; DING-SHINN CHEN ; Liaw Y.-F.; PAN-CHYR YANG ; Huang Y.-H.; Chen C.-J. | The Lancet | 1 | 1 | |
2 | 2013 | Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients | Yuan Q.; Song L.-W.; CHUN-JEN LIU ; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Gut | 67 | 63 | |
3 | 2011 | Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling | Hsu C.-S.; Chen H.-C.; Jeng J.; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 0 | 0 | |
4 | 2009 | Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease | Hsu C.-S.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 0 | 0 | |
5 | 2009 | Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy | TAI-CHUNG TSENG ; CHUN-JEN LIU ; SONG-CHOU HSIEH ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Digestive and Liver Disease | 3 | 3 | |
6 | 2009 | Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; Tsai H.-B.; Hung P.-H.; SHIH-JER HSU ; Chen S.-L.; JOU-WEI LIN ; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gut | 26 | 23 | |
7 | 2008 | Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infection | TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 0 | 0 | |
8 | 2007 | APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers [5] | TUNG-HUNG SU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 0 | 0 | |
9 | 2007 | Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6] | CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | New England Journal of Medicine | 1 | 1 | |
10 | 2006 | Mixed hepatitis B virus genotype infections: The more, the worse? [3] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 8 | 5 | |
11 | 2006 | Local ablation vs. resection for the treatment of hepatocellular carcinoma [1] | JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 5 | 4 | |
12 | 2006 | Reply [3] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 0 | 0 | |
13 | 2006 | Kinetics of Hepatitis B Virus Reactivation After Chemotherapy: More Questions Than Answers | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Gastroenterology | 7 | 7 | |
14 | 2006 | Clinical significance of occult hepatitis B virus infection cannot be overlooked [11] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Clinical Infectious Diseases | 1 | 1 | |
15 | 2006 | Reply [2] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 0 | 0 | |
16 | 2005 | HBV genotypes and outcome of HBV infection [1] (multiple letters) | JIA-HORNG KAO ; DING-SHINN CHEN ; Lok A.S.F. | Hepatology | 7 | 6 | |
17 | 2004 | Hepatitis B Virus Genotypes and Core Promoter Variant [10] (multiple letters) | JIA-HORNG KAO ; DING-SHINN CHEN ; Lok A.S.F. | Gastroenterology | 0 | 1 | |
18 | 2004 | A forgotten population with chronic hepatitis C infection: Subjects coinfected with hepatitis B virus [1] | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | 14 | 12 | |
19 | 2003 | Molecular Assays for Hepatitis B Virus Infection [1] | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 5 | 5 | |
20 | 2003 | Clinical Relevance of Hepatitis B Virus Genotypes Ba and Bj in Taiwan [6] (multiple letters) | JIA-HORNG KAO ; DING-SHINN CHEN ; Sugauchi F.; Miyakawa Y.; Mizokami M. | Gastroenterology | 18 | 14 | |
21 | 2002 | Hepatitis B viral genotypes and lamivudine resistance [1] | JIA-HORNG KAO ; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Hepatology | 101 | 84 | |
22 | 2001 | Mother-to-child HCV transmission [1] (multiple letters) | Semprini A.E.; Savasi V.; Hollander L.; Tanzi E.; Fiore S.; Newell M.-L.; Pembrey L.; Zanetti A.; Coll O.; Numazaki K.; Fujikawa T.; Chiba S.; Hari P.; Prasad C.G.K.; Lankipalli R.; HO-HSIUNG LIN ; JIA-HORNG KAO ; DING-SHINN CHEN ; Gibb D.M.; Dunn D.T.; Goodall R.L. | Lancet | 7 | 3 | |
23 | 1997 | Blood-bank screening for hepatitis G [14] | JIA-HORNG KAO ; PEI-JER CHEN ; JIN-TOWN WANG ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 7 | 5 | |
24 | 1996 | Mechanism of vertical transmission of hepatitis G [6] | HO-HSIUNG LIN ; IA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Lancet | 40 | 27 | |
25 | 1996 | GBV-C in the aetiology of fulminant hepatitis [6] | JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Mishiro S.; Yoshiba M.; Okamoto H. | Lancet | 83 | 87 | |
26 | 1996 | GBV-C/HGV infection and aplastic anaemia [7] | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 9 | 8 | |
27 | 1995 | Reply To the Editor | Lin H.-H.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | The Journal of Pediatrics | 0 | 0 | |
28 | 1994 | Alleles Lost and Gained in Malignant Cells | PEI-JER CHEN ; Shiou-Hwei Yeh ; DING-SHINN CHEN ; Burke H.B.; Hamilton S.R.; Jen J.; Vogelstein B. | New England Journal of Medicine | 2 | 3 |